Initial testing (stage 1) of M6620 (formerly VX-970), a novel ATR inhibitor, alone and combined with cisplatin and melphalan, by the Pediatric Preclinical Testing Program.
Pediatric Blood & Cancer
Kurmasheva, Raushan T RT; Kurmashev, Dias D; Reynolds, C Patrick CP; Kang, Min M; Wu, Jianwrong J; Houghton, Peter J PJ; Smith, Malcolm A MA